Research
Insight into COVID-19 available Vaccines Authorised for Emergency Use
Author(s): Nuha A. Alkhattabi*
In December of 2019, SARS-CoV2, a member of the coronavirus family, started to spread rapidly worldwide. The pandemic known as COVID-19 has resulted in mortality from respiratory disorders in 2,413,912 people to date, according to the World Health Organization. It has also necessitated hospitalization and intensive care for many people around the world, exceeding the capacity of hospitals. The rapid transmission of this virus is an important characteristic that requires individuals to take strict precautions to protect themselves. To date, there is no known treatment for COVID-19, but pharmaceutical companies, collaborating wit.. Read More»
Select your language of interest to view the total content in your interested language